Starton Therapeutics Inc.
PARAMUS, NJ · Founded 2017 · CIK 0001743192 · Biotech · Private
Proprietary controlled delivery system for reformulating FDA-approved drugs with improved pharmacokinetic profiles
startontx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $11M
- 9 Form D · Oct 2024
- 24 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 32
- 5 granted · 27 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $766,677 | |
| Private capital raised | Form D · SEC | $2,038,703 | |
| Private capital raised | Form D · SEC | $77,597 | |
| Private capital raised | Form D · SEC | $1,145,375 | |
| Private capital raised | Form D · SEC | $1,145,350 | |
| Private capital raised | Form D · SEC | $1,023,417 | |
| Private capital raised | Form D · SEC | $1,443,520 | |
| Private capital raised | Form D · SEC | $970,930 | |
| Private capital raised | Form D · SEC | $2,126,035 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3297 | PHELIX THERAPEUTICS LLC | — | — |
| 3298 | Ferment Labs, Inc. | — | $900K |
| 3299 | Rhamnolipid, Inc. | — | $1.0M |
| 3300 | Starton Therapeutics Inc. | — | $11M |
| 3301 | Knopp Biosciences LLC | — | $159M |
| 3302 | Hemp Synergistics LLC | — | $1.5M |
| 3303 | Stramsen Biotech, Inc. | — | $5.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Kenneth AndersonDirector
- KENNETH ANDERSONDirector
- Eric BaumDirector
- ERIC BAUMDirector
- Asher Chanan-KhanDirector
- Keith DarraghExecutive Officer
- KEITH DARRAGHExecutive Officer
- Moses DodoDirector
- Mohamad HusseinDirector
- MOHAMAD HUSSEINDirector
- Scott KahnExecutive Officer
- Nintin KaushalDirector
- Nitin KaushalDirector
- NITIN KAUSHALDirector
- Pedro LichtingerDirector · Executive Officer
- PEDRO LICHTINGERDirector · Executive Officer
- Pedro Lichtinger WaismanDirector · Executive Officer
- Jamie OliverExecutive Officer
- LITSA PERPERIDISPromoter
- Fotios PlakogiannisDirector
- FOTIOS PLAKOGIANNISDirector
- Roman RogolDirector
- ROMAN ROGOLDirector
- Cidnee VaykovichDirector · Executive Officer
- CIDNEE VAYKOVICHDirector · Executive Officer
- Pedro WaismanDirector · Executive Officer
- ROY WALDONDirector
- Roy WaldronDirector
- ROY WALDRONDirector
Patents
- Controlled Release Delivery Of Low Water Solubility Compounds Via Oral Administrationapplication
- Stable Solutions of Immunomodulatory Imide Compounds for Parenteral Usegranted
- Treatment of Vomiting and Nausea with Minimum Dose of Olanzapinegranted
- Molecular Solid Suspensions For Transdermal Drug Deliveryapplication
- Continuous Delivery Of Lenalidomide And Other Immunomodulatory Agentsapplication
- Continuous Delivery of Lenalidomide and Other Immunomodulatory Agentsgranted
- Treatment Of Vomiting And Nausea With Minimum Dose Of Olanzapinegranted
- Treatment of Vomiting and Nausea with Minimum Dose of Olanzapineapplication
- Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Lenalidomide and Other Immunomodulatory Agentsapplication
- Use Of Olanzapine For Treatment Of Parp-inhibitor-induced Nauseaapplication
- Continuous Delivery Of Lenalidomide And Other Immunomodulatory Agentsgranted
- Compositions For Transdermal Administration Of Olanzapine And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.